Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1K Sell
52
-288
-85% -$6.45K ﹤0.01% 10128
2014
Q2
$8K Sell
340
-108,001
-100% -$2.45M ﹤0.01% 9074
2014
Q1
$2.64M Buy
108,341
+107,963
+28,562% +$2.78M ﹤0.01% 2500
2013
Q4
$10K Sell
378
-992
-72% -$25K ﹤0.01% 8951
2013
Q3
$36K Sell
1,370
-1,266
-48% -$32.8K ﹤0.01% 7283
2013
Q2
$65K Buy
+2,636
New +$58.3K ﹤0.01% 6400

Other funds holding ADTN

UBS's ADTN Position: Q3 2014 in Review

UBS reduced its Adtran (ADTN) stake by 85% in Q3 2014, selling an estimated $6.45K and leaving 52 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10128.

UBS first reported a position in ADTN in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.64M in Q1 2014. 147 funds tracked by Wall St. Rank hold ADTN as of Q3 2014.

  • UBS held 52 shares of Adtran worth $1K as of Q3 2014.
  • UBS sold 288 Adtran shares in Q3 2014, an estimated $6.45K.
  • Adtran made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10128 holding.
  • UBS first reported a position in Adtran in Q2 2013 and has held it in 6 quarters since.
  • UBS's Adtran position peaked at $2.64M in Q1 2014.
  • 147 funds tracked by Wall St. Rank held Adtran as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.